Evernorth Adds to Digital Formulary

The additions include apps to help people better manage their sleep issues, anxiety, alcohol and opioid use disorders, and inflammatory conditions.

Evernorth, a Cigna company, has expanded its Digital Health Formulary to include five new app-based programs to help people better manage their sleep issues, anxiety, alcohol and opioid use disorders, and inflammatory conditions.

“The latest additions give patients access to new and affordable options to improve and maintain their health while making it easier and cost-effective for our clients to include these solutions in their benefit plans,” Glen Stettin, M.D., chief innovation officer at Evernorth, said in a press release.

The five new digital solutions that have been added include:

  • Big Health’s Sleepio forinsomnia
  • Big Health’s Daylight foranxiety
  • Quit Genius for alcohol use disorder
  • Quit Genius for opioid use disorder
  • HealthBeacon’s Injectable Care Management System for inflammatory condition

The company said each solution on the Digital Health Formulary has been clinically reviewed and evaluated. The solutions are also evaluated for privacy, user experience, and affordability.

Plan sponsors can choose to offer individual digital solutions or incorporate them into one of Evernorth’s connected care programs, which safely integrates biometric data from the digital health solutions with pharmacy, medical, and lab data. The health apps have helped provide average savings of $120,000 per solution for health plans, according to the company.

Evernorth has also launched a series of pilot programs to evaluate the clinical impact and user experience. These include:

  • Jasper for oncology
  • Zerigo for psoriasis and eczema
  • Hinge Health for women’s pelvic health (Hinge Health's Digital Musculoskeletal Clinic that was added as a preferred solution in 2021)
  • Lid Sync for medication treatment adherence